Skip To Main Content
Yinghui Zhu on Muck Rack

Yinghui Zhu

As seen in: Frontiers, Journal of Retailing and Consumer Services, MDPI, BioRxiv, The Journal of Clinical Investigation, Blood
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinghui

Contact Yinghui, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effects of different HTO correction angles on ankle joint biomechanics in 3D varus knee model: a patient-specific simulation study

|
By Yinghui Zhu, Adeel Anwar, Yufang Zhang, Weiguo Zhang, Zhen Zhang, Mengke Ren
| Frontiers
Abstract Objective: The mechanical axis in the varus knee deteriorates normal ankle joint biomechanics. Consequently, degrees of correction angles may also alter ankle stresses. This study aimed to elaborate the stress changes in articular cartilages and pressure in the subtalar joint of the ankle joint using finite element analysis (FEA) with different osteotomy correction angles.
Open in Who Shared Issue with article?

Corrigendum to Identification of CD84 as a potent survival factor in acute myeloid leukemia

|
By Yinghui Zhu, Mariam Murtadha, Miaomiao Liu, Enrico Caserta
| The Journal of Clinical Investigation
Corrigendum Open Access | 10.1172/JCI196910 Published in Volume 135, Issue 15 on August 1, 2025 J Clin Invest. 2025;135(15):e196910. https://doi.org/10.1172/JCI196910. © 2025 Zhu et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. View PDF Yinghui Zhu, … , John C. Williams, Flavia Pichiorri CD84 is a key survival protein for leukemia cells and a potential target to treat AML.
Open in Who Shared Issue with article?

Identification of CD84 as a potent survival factor in acute myeloid leukemia

|
By Yinghui Zhu, Mariam Murtadha, Miaomiao Liu, Enrico Caserta
| The Journal of Clinical Investigation
Abstract Acute myeloid leukemia (AML) is an aggressive and often deadly malignancy associated with proliferative immature myeloid blasts. Here, we identified CD84 as a critical survival regulator in AML. High levels of CD84 expression provided a survival advantage to leukemia cells, whereas CD84 downregulation disrupted their proliferation, clonogenicity, and engraftment capabilities in both human cell lines and patient-derived xenograft cells.
Open in Who Shared View Duplicates (2) Issue with article?
See all 9 licensed articles (10 Total)